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Background. Podocalyxin is a CD34-related transmembrane protein involved in hematopoietic cell homing, kidney
morphogenesis, breast cancer progression, and epithelial cell polarization. Although this sialomucin has been shown to block
cell adhesion, the mechanisms involved remain enigmatic. It has, however, been postulated that the adaptor proteins NHERF-1
and 2 could regulate apical targeting of Podocalyxin by linking it to the actin cytoskeleton. Principal Findings. Here, in
contrast, we find that full-length Podocalyxin acts to recruit NHERF-1 to the apical domain. Moreover, we show that ectopic
expression of Podocalyxin in epithelial cells leads to microvillus formation along an expanded apical domain that extends
laterally to the junctional complexes. Removal of the C-terminal PDZ-binding domain of Podocalyxin abolishes NHERF-1
recruitment but, surprisingly, has no effect on the formation of microvilli. Instead, we find that the extracellular domain and
transmembrane region of Podocalyxin are sufficient to direct recruitment of filamentous actin and ezrin to the plasma
membrane and induce microvillus formation. Conclusions/Significance. Our data suggest that this single molecule can
modulate NHERF localization and, independently, act as a key orchestrator of apical cell morphology, thereby lending
mechanistic insights into its multiple roles as a polarity regulator, tumor progression marker, and anti-adhesin.
Citation: Nielsen JS, Graves ML, Chelliah S, Vogl AW, Roskelley CD, et al (2007) The CD34-Related Molecule Podocalyxin Is a Potent Inducer of
Microvillus Formation. PLoS ONE 2(2): e237. doi:10.1371/journal.pone.0000237
INTRODUCTION
The apical surface of adherent cells is a highly specialized domain
that, in differentiated epithelia, is characterized by microvilli.
These structures act as high surface area transport sites, and their
formation coincides with the polymerization of f-actin at the core
of the microvilli and recruitment of the ezrin/radixin/moesin
(ERM) family of proteins to the apical domain, presumably to act
as linkers between the cytoskeleton and transmembrane proteins
(reviewed in [1]). Despite their clear biological importance and the
striking membrane remodeling that coincides with their formation,
the mechanism of microvillus assembly during epithelial morpho-
genesis remains poorly understood.
Podocalyxin/PCLP-1/MEP21/gp135 is a cell surface sialomu-
cin closely related to CD34 and Endoglycan [2,3,4]. These three
proteins each have a conserved cytoplasmic tail with a C-terminal
PDZ recognition site, a transmembrane region, and an extracel-
lular domain with extensive glycosylation, providing a bulky,
negatively-charged structure [2]. Podocalyxin is a ,140 kDa
protein expressed on the surface of vascular endothelia, mesothe-
lial cells, hematopoietic progenitors, megakaryocytes, kidney
podocytes, luminal breast epithelial cells, and a subset of neurons
[5,6,7,8,9,10]. It was first identified as the major sialylated
glycoprotein of renal glomerular epithelial cells (podocytes), and
we have since shown that it is essential for their structure and
function [2,5]. Specifically, Podocalyxin knockout mice generate
normal numbers of podocyte precursors, but they fail to generate
the extensive, highly-interdigitated foot processes typical of
differentiated podocytes and instead retain cell junctions between
immature podocytes [2]. Thus, loss-of-function studies implicate
Podocalyxin in specialized epithelial cell morphogenesis.
It has been hypothesized that the normal function of
Podocalyxin is to act as an ‘‘apicalizing’’ factor and an anti-
adhesin that can disrupt cell-cell contacts between epithelial cells,
and that overexpression can lead to altered morphologies
associated with cancer progression [8,11,12]. How these processes
are regulated at the ultrastructural level, however, has not been
elucidated. To define the cytosolic components that link
Podocalyxin to the cytoskeleton and regulate its activity as
a blocker of adhesion, a number of groups have screened for
intracellular Podocalyxin-binding proteins [13,14,15]. This led to
the identification of the extremely versatile NHERF (Na+/H+
exchanger regulatory factor) family of adaptor proteins (reviewed
in [16,17]) as Podocalyxin binding partners. NHERF-1/EBP-50
and NHERF-2/E3KARP/TKA-1 are closely related adapter
proteins bearing two N-terminal PDZ domains and a C-terminal
ERM domain. These proteins bind the C-terminus of a variety of
membrane receptors via their PDZ domains and link them to
cytoskeletal components through their conserved ERM domain.
They have been implicated in regulating a wide variety of
biological processes including ion transport, signal transduction,
and growth control; known ligands for NHERF PDZ domains
include G protein coupled receptors, receptor tyrosine kinases, and
transcription factors (reviewed in [18]).
The discovery that NHERF-1 and 2 bind the C-terminal
DTHL motif of Podocalyxin’s cytosolic tail has led to speculation
that formation of NHERF/Podocalyxin complexes may be the key
mechanistic step in 1) formation of apical domains in epithelial
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cells or during tumor progression, 3) generation of highly-
interdigitated foot processes for normal podocyte function, and
4) blocking hematopoietic cell adhesion [2,8,11,12,13,15,16].
Although it has been suggested that NHERFs are responsible for
the localization of Podocalyxin in each of these scenarios, this has
not been demonstrated conclusively [12,14].
To clarify the role of Podocalyxin and NHERFs in regulating
cell polarity and epithelial morphogenesis, we have ectopically
expressed full-length Podocalyxin and various deletion mutants in
epithelial cell lines. Strikingly, we find that Podocalyxin is a robust
inducer of apical microvillus formation and that these structures
recruit f-actin in a manner characteristic of normal microvilli in
vivo. Surprisingly, however, this process required only the
extracellular domain and transmembrane region of Podocalyxin;
the bulk of the cytoplasmic domain including all phosphorylation
sites and the highly conserved NHERF binding domain were
completely dispensable for this function. When present, however,
Podocalyxin’s cytoplasmic tail potently recruited NHERF-1 to the
apical plasma membrane; in its absence NHERF-1 was dispersed
throughout the cell, suggesting that Podocalyxin may modulate
NHERF function by regulating its apical membrane localization.
Our results suggest that Podocalyxin is a potent regulator of
epithelial cell morphogenesis, which may provide mechanistic
clues to its previously described role in blocking cell adhesion and
as a marker of aggressive cancers when overexpressed.
RESULTS
Podocalyxin is a potent inducer of microvillus
formation
Since Podocalyxin is normally found in polarized cells with highly
distinctive cell surface extensions, we investigated the possibility that
this molecule may be directly involved in generation of such
structures. MDCK kidney epithelial and MCF-7 breast carcinoma
cell lines were stably transfected with constructs encoding full-length
murine Podocalyxin and the morphologies of resulting bulk
populations were examined by transmission electron microscopy
(TEM). In Podocalyxin-transfected cells, but not cells transfected with
empty vector, we observed a striking increase in microvillus formation
(figure 1A–D). This phenomenon was even more apparent upon
scanning electron microscopy (SEM) analysis of clonally isolated
populationsoftransfectedcells(figure1E–H).Quantificationrevealed
a 2-3-fold increase in microvillus numbers in Podocalyxin-transfected
cells (figure 1I). We therefore conclude that ectopic expression of
Podocalyxin is sufficient to induce the formation of microvilli.
Intact actin filaments are an essential component of normal
microvilli. MCF-7 and MDCK cells were therefore treated with
latrunculin A, an inhibitor of actin polymerization, to determine if
the Podocalyxin-induced cell surface projections were structurally
dependent on f-actin. Confocal microscopic analysis revealed
colocalization of f-actin and Podocalyxin in a punctate pattern at
the apical cell surface where microvilli form in untreated
Podocalyxin-transfected cells (figure 2). In vector-transfected cells,
apical actin was more diffuse and less abundant, demonstrating
that Podocalyxin is capable of apical actin recruitment, as shown
previously [19]. Strikingly, latrunculin A treatment of Podoca-
lyxin-transfected cells led to loss of actin filaments, including
apically localized f-actin, and redistribution of Podocalyxin into
a diffuse pattern at the cell surface. Together, these data
demonstrated that Podocalyxin induces formation of typical
actin-dependent microvillar structures.
Previously we found that Podocalyxin expression is an in-
dependent indicator of invasive breast cancer with very poor
Figure 1. Podocalyxin induces microvillus formation. MDCK (A, B, E, F)
and MCF-7 (C, D, G, H) cells transfected with murine Podocalyxin (B, D,
F, H) or empty vector (A, C, E, G) and examined by TEM (A–D; scale bar:
1 mm) and SEM (E–H; scale bar: 2 mm). In TEM images, vertical slices are
shown near the apical cell surface with some of the numerous
additional microvilli labeled with red arrows. Many microvilli are visible
as small circles as they are seen in cross-section. SEM images are of the
apical cell surface with microvilli evident as thin surface projections. (I)
Microvilli in six 50 mm
2 fields were enumerated and graphed. Averages
are shown; error bars represent standard deviation. T-tests were used to
show statistically significant differences between vector and Podoca-
lyxin-transfected cells, with p,0.002 in both cases. Representative of
two independent experiments.
doi:10.1371/journal.pone.0000237.g001
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leads to subtle alterations of cell junctions and shedding of cells
from confluent, high density monolayers [8]. In an effort to
correlate these observations with microvillus formation, we used
confocal imaging to determine the morphology and microvillus
status of cells expressing Podocalyxin in monolayers. As shown in
figure 3 and, more strikingly, in supplemental figure S1, MCF-7
cells expressing high levels of Podocalyxin exhibited a distinctive
apical expansion above surrounding cells in these monolayers. This
correlated closely with the appearance of a ‘‘shag-rug’’ morphol-
ogy on the apical face of these cells as detected by Podocalyxin
staining (figure 3A, inset). The same phenotype was observed in
human ovarian carcinoma and normal murine mammary
epithelial cell lines overexpressing Podocalyxin (data not shown).
We conclude that monolayer disruption, progressive loss of cell
contacts, and decreased integrity of cell junctions induced by
Podocalyxin is likely linked to its ability to induce the apical
domain expansion that is associated with microvillus formation.
Podocalyxin recruits NHERF-1, f-actin, and ezrin to
the apical membrane
We, and others, have shown previously that Podocalyxin can
interact with NHERF-1 and NHERF-2 [12,13,14,15,19]. Since
NHERF molecules act as scaffolding proteins and associate with
actin through ezrin, it was assumed that NHERF proteins were
responsible for apical localization of Podocalyxin. Surprisingly,
here we observed the opposite. In control MCF-7 cells endogenous
NHERF-1 was diffusely localized throughout the cytoplasm,
whereas in Podocalyxin-transfected cells there was a dramatic
increase in apically localized NHERF-1 and a concomitant
decrease in cytoplasmic staining (figure 3B, C). Thus, Podocalyxin
is capable of recruiting NHERF-1 to apical domains.
Podocalyxin and NHERF-1 both interact with the actin-binding
protein ezrin [20,21]. Since ezrin is an important component of
microvilli, we sought to determine the localization of endogenous
ezrin and f-actin at the apical plasma membrane in cells expressing
Podocalyxin. High resolution confocal analysis revealed that in
cells lacking ectopic Podocalyxin expression, ezrin localized to
small discrete puncta and did not colocalize with f-actin. In
contrast, in cells ectopically expressing Podocalyxin, both ezrin
and f-actin were enriched at the apical membrane and
dramatically colocalized with Podocalyxin in microvillar structures
(figure 4). Taken together, overexpression of Podocalyxin induced
the formation of apical actin-dependent microvilli, enriched with
NHERF-1 and ezrin.
Since ezrin is known to link transmembrane proteins to the
actin cytoskeleton, we assessed the role of ezrin in the recruitment
of Podocalyxin to the apical membrane by transiently expressing
a dominant-negative mutant of the molecule (N’ezrin [22]) in
MCF-7 cells already stably expressing Podocalyxin (figure 5).
When N’ezrin was expressed in pre-formed, fully polarized
monolayers, Podocalyxin and NHERF-1 both remained localized
at the apical membrane (figure 5A, B). A considerable amount of
the N’ezrin itself was also targeted to the apical domain in these
cells (figure 5A) although, as expected [22], the mutant protein was
also targeted to basal and basolateral domains (figure 5B). We also
expressed N’ezrin in cells prior to monolayer formation, which
allowed us to examine protein localization as polarity was being
Figure 2. Podocalyxin-induced microvilli are structurally dependent
on intact actin filaments. MDCK (A) and MCF-7 (B) cells transfected
with murine Podocalyxin or empty vector were treated with the actin
disrupting agent latrunculin A (LatA) or DMSO (negative control) and
then fixed. Podocalyxin was labeled with an anti-Podocalyxin antibody
(green); f-actin was labeled with phalloidin (red), and nuclei were
labeled with DAPI (blue). Scale bar: 5 mm.
doi:10.1371/journal.pone.0000237.g002
Figure 3. Podocalyxin induces apical expansion and recruits NHERF-1
to the apical membrane. 3D images of empty vector and Podocalyxin-
transfected MCF-7 cells showing ectopic Podocalyxin (red), endogenous
NHERF-1 (green), and DAPI (blue) labeling. Dimensions of blue
rectangles: 118626 mm. (A) Podocalyxin-transfected cells labeled with
an anti-Podocalyxin antibody. (B) The same cells labeled with an anti-
NHERF-1 antibody. (C) Merged images showing Podocalyxin, NHERF-1,
and DAPI labeling. Inset in (A): projection of apical surface of a single
Podocalyxin-transfected MCF-7 cell, labeled with an anti-Podocalyxin
antibody.
doi:10.1371/journal.pone.0000237.g003
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at apical, lateral, and basal surfaces (figure 5D). The same was not
true of Podocalyxin and NHERF-1, which were found mainly
apically and laterally as polarity was being established. Impor-
tantly, there was no difference in Podocalyxin and NHERF-1
localization in neighboring cells that did not express mutant
N’ezrin. Thus, while we cannot rule out subtle differences in
localization, it appears that ezrin is not likely required for
Podocalyxin’s apical targeting or its ability to recruit NHERF-1
to the apical domain and retain it there. This does preclude the
possibility, however, that Podocalyxin may be capable of
regulating the localization of endogenous, wild type ezrin (see
figures 4 and 9).
In order to gain further insights into the mechanisms involved in
Podocalyxin-induced NHERF-recruitment and microvillus forma-
tion, we generated a series of MCF-7 clones expressing wild-type
avian Podocalyxin or the following three deletion mutants: 1)
‘‘DDTHL,’’ lacking the C-terminal DTHL motif essential for
Figure 4. Podocalyxin induces apical recruitment of f-actin and ezrin, and all three molecules colocalize in microvilli. Projections of apical
confocal images of MCF-7 cells transfected with murine Podocalyxin or empty vector showing ectopic Podocalyxin (blue), endogenous ezrin (green),
and f-actin (red) labeling. White represents colocalization of all three molecules. Note the long extended microvilli in the Podocalyxin-transfected
sample. Scale bars: 5 mm.
doi:10.1371/journal.pone.0000237.g004
Figure 5. Apical localization of Podocalyxin and NHERF-1 is not dependent on ezrin. MCF-7 cells stably expressing ectopic murine Podocalyxin
were either transfected with VSV-tagged dominant negative (N-terminal) ezrin after formation of monolayers and appropriate localization of
Podocalyxin and NHERF-1 (A, B) or transfected with VSV-tagged N’ezrin and then replated before immunostaining (C, D). (A–D) Immunolabeling of
VSV-tagged N’ezrin (green), ectopic Podocalyxin (red), and endogenous NHERF-1 (blue). Purple represents apical colocalization of Podocalyxin and
NHERF-1 in cells not expressing dominant negative ezrin (internal negative control); white represents apical colocalization of all three moleculesi n
cells expressing dominant negative ezrin. Scale bars: 5 mm. (A, C) Projections of merged confocal stacks taken near the apical cell surface showing
individual colors and merged images; (B, D) vertical slices of confocal stacks.
doi:10.1371/journal.pone.0000237.g005
Podocalyxin Induces Microvilli
PLoS ONE | www.plosone.org 4 February 2007 | Issue 2 | e237interaction with NHERF proteins [14,15]; 2) ‘‘Dtail,’’ lacking the
entire cytoplasmic tail with the exception of the juxtamembrane
sequence HQRF, which was retained as a membrane anchor (this
mutant lacks all potential phosphorylation sites, the C-terminal
NHERF-binding site, and a recently described ezrin-binding site)
[3,4,19,23]; and, finally, 3) ‘‘DEC,’’ lacking the majority of the
extracellular domain (including the mucin domain and the
cysteine-bonded globular domain) and instead encoding an
extracellular ‘‘flag-tag,’’ Podocalyxin’s transmembrane region,
and its full-length cytoplasmic tail (figure 6A). Avian Podocalyxin
was chosen as the basis for these experiments for three reasons: 1)
it is 85% identical to mammalian Podocalyxin in its intracellular
domain, 2) as with the murine protein used in the above
experiments, wildtype avian Podocalyxin also induced microvillus
formation in MCF-7 cells, and 3) ectopic expression could be
selectively detected using a species-specific monoclonal antibody
that reacts with native, fixed, and denatured forms of the molecule
[3]. MCF-7 cells were transfected with these constructs, and clones
were isolated based on similar levels of ectopic Podocalyxin
expression as determined by FACS (figure 6B).
As shown in figure 7, full-length Podocalyxin showed strong
colocalization with endogenous NHERF-1 at the apical mem-
brane, while DDTHL and Dtail mutants, both of which lack the C-
terminal NHERF binding motif, did not. In contrast, the DEC
mutant lacking the extracellular domain but retaining the entire
cytoplasmic tail of Podocalyxin was apically targeted and
colocalized with NHERF-1. This further demonstrates that
Podocalyxin recruits NHERF-1 to the apical domain through its
C-terminal DTHL motif.
Although the cytoplasmic domain is dispensable,
the extracellular domain of Podocalyxin is required
for microvillus formation
We then assessed how loss of the Podocalyxin/NHERF-1
interaction affected microvillus formation. MCF-7 cells transfected
with the Podocalyxin mutants described above were used for
analysis of microvillus formation by TEM and SEM. TEM
demonstrated that, as expected, control cells had few microvilli
while cells transfected with full-length Podocalyxin displayed
Figure 6. Schematic of Podocalyxin mutants and FACS expression profiles. (A) Podocalyxin mutants. Blue: extracellular domain, horizontal bars:
carbohydrates/sialic acid residues, red: transmembrane region, purple: cytoplasmic tail (including C-terminal DTHL in wildtype and DEC), and green:
flag-tag replacing most of Podocalyxin’s extracellular domain. (B) FACS profiles demonstrating comparable Podocalyxin expression levels in sorted
clones. Dashed lines represent negative controls (vector-transfected cells stained with the same antibodies); solid lines represent Podocalyxin
expression. Note: all mutants were detected with an anti-Podocalyxin antibody with the exception of DEC, which was detected with an anti-flag
antibody.
doi:10.1371/journal.pone.0000237.g006
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cells expressing DDTHL or Dtail mutants generated microvilli in
similarnumbersto full-length Podocalyxin transfectants.Conversely,
the extracellular domainof Podocalyxin was found to be essential for
this phenotype since there was no increase in microvilli in cells
expressing the DEC mutant bearing only the flag-tagged trans-
membrane region and the entire cytoplasmic domain of Podoca-
lyxin,eventhoughthismutantwasabletoapicallyrecruitNHERF-1
(see figure 7, above). This result was confirmed via SEM analysis
(figure 8B).Inordertoquantitate thiseffect, allmicrovilliobservedin
six random 50 mm
2 (15 0006) SEM fieldswereenumeratedfor each
mutant (figure 8C). Full-length, DDTHL, and Dtail transfectants all
had at least twice as many microvilli as vector-control and DEC
transfectants. We therefore conclude that the extracellular domain,
transmembrane region, and four amino acids of Podocalyxin’s
cytoplasmic tail are sufficient to induce NHERF-1-independent
formation of epithelial microvilli.
It has been shown that maintenance of podocyte foot process
integrity is critically dependent on the negatively-charged glycosyla-
tionsdecoratingPodocalyxin’sextracellulardomain[5,24,25].Itwas
thereforenotsurprisingthatdeletionofthemajorityofPodocalyxin’s
extracellular domain also prevented microvillus formation in
MCF-7 cells. In order to more precisely assess the role of sialic
acid residues in microvillus formation, SEM analysis was performed
on Podocalyxin-transfected MCF-7 cells after treatment with
neuraminidase to remove these residues from Podocalyxin’s
mucin-like domain. Unexpectedly, however, treatment with neur-
aminidase either before or after microvillus formation did not affect
the level of cell surface protrusions (data not shown).
Microvillus formation and recruitment of ezrin and
f-actin occur in the absence of NHERF-binding
It was surprising that the highly conserved, NHERF-binding,
cytoplasmic tail of Podocalyxin was dispensable for microvillus
Figure 7. Podocalyxin’s C-terminal DTHL motif is required for
recruitment of NHERF-1. Projections of apical confocal images of
transfected MCF-7 cells showing ectopic Podocalyxin (red), endogenous
NHERF-1 (green), and DAPI (blue) labeling. Isotype control sample is
Podocalyxin-transfected cells labeled with anti-Podocalyxin (red) and
NHERF-1 isotype control (green) to demonstrate lack of non-specific
NHERF-1 staining. White numbers represent Pearson’s colocalization
coefficient. Scale bar: 5 mm.
doi:10.1371/journal.pone.0000237.g007
Figure 8. Podocalyxin’s extracellular domain and the first four amino
acids of its cytoplasmic tail are necessary and sufficient for
microvillus formation. (A) TEM images of MCF-7 cells transfected with
vector or full-length and mutant Podocalyxin. Vertical slices are shown
near the apical cell surface with some of the numerous additional
microvilli labeled with red arrows. Scale bar: 1 mm. (B) SEM images at
the apical surface of transfected MCF-7 cells with microvilli evident as
thin surface projections. Scale bar: 2 mm. (C) Microvilli in six 50 mm
2
fields were enumerated and graphed. Averages are shown; error bars
represent standard deviation. T-tests were used to show statistically
significant differences between vector and Podocalyxin-transfected
cells, and between wildtype Podocalyxin and DEC-transfected cells with
p,0.003 in all cases. Representative of two independent experiments.
doi:10.1371/journal.pone.0000237.g008
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actin cytoskeleton is essential for maintaining cell shape, and that
linkage of actin to the plasma membrane is important for
generating and supporting cell surface protrusions, including
microvilli [26]. Since NHERF-1 and 2 can connect Podocalyxin to
the actin cytoskeleton through ezrin [13,15,27], we initially
assumed that Podocalyxin’s involvement in the formation of
microvilli would require interaction with NHERFs. Moreover,
NHERF-2 interactions with Podocalyxin have recently been
shown to coincide closely with the formation of a ‘‘pre-apical
domain’’ in MDCK cells, and it was postulated that this
association was a prerequisite for the formation of this domain
[12]. However, our data suggest that although the C-terminal tail
of Podocalyxin is sufficient to actively recruit NHERF-1 to apical
plasma membrane domains, the formation of microvilli and,
indeed, the apical targeting of Podocalyxin to the plasma
membrane, both occur in the absence of direct interaction with
NHERF-1 (MCF-7 cells do not express appreciable amounts of
NHERF-2, data not shown).
Interestingly, all forms of Podocalyxin, regardless of whether
or not they contained a NHERF-binding sequence, displayed
increased apical recruitment of endogenous ezrin and strong
colocalization with this protein (figure 9A, B). Thus, recruitment of
wild type ezrin to the apical membrane can also occur in the
absence of any direct interaction of Podocalyxin with NHERF.
Schmieder et al recently demonstrated, however, that the
juxtamembrane region of Podocalyxin’s cytoplasmic tail can
interact directly with ezrin, and that the histidine, arginine, and
serine residues in the juxtamembrane HQRIS sequence of rat
Podocalyxin are particularly important for this interaction [19].
This sequence is similar to the ezrin-binding site in the
juxtamembrane region of intercellular adhesion molecule
(ICAM)-3’s cytoplasmic tail [19,28]. Although the binding of our
Podocalyxin Dtail mutant (with the cytoplasmic tail HQRF)
directly to ezrin remained a formal possibility, Serrador et al have
shown that truncation of ICAM-3’s cytoplasmic tail after the
REHQRSGS sequence completely abolishes ezrin binding [28].
To confirm that our truncation eliminated any residual ezrin
binding, we performed in vitro binding assays using biotinylated
peptides corresponding to our Dtail mutant (HQRF), a longer
peptide (HQRFSQKKSQQRLTEELQ) containing the previous-
ly described ezrin binding site, and the full-length Podocalyxin tail
[19,28]. Although we obtained reproducible binding of ezrin to
the two longest peptides, we did not observe any interaction
between ezrin and our truncated peptide (figure 9C) or a control
peptide containing amino acids 53–73 of the Podocalyxin
cytoplasmic tail (data not shown). Thus, although several
important amino acids are retained in the Dtail mutant, a longer
sequence is apparently required for directly interacting with ezrin.
In summary, our results suggest that apical recruitment of ezrin
and the formation of microvilli were not dependent on direct
interaction of Podocalyxin with ezrin or on indirect interaction
through NHERF proteins.
Apical recruitment of f-actin was also independent of NHERF-
binding or direct interaction of Podocalyxin with ezrin. All forms
of Podocalyxin demonstrated apical colocalization with f-actin,
although apical recruitment was notably less robust in the absence
of the extracellular domain (figure 10A, B). Consistent with the
SEM and TEM data, cells expressing extracellular-domain-
containing Podocalyxin mutants exhibited a clear punctate
staining pattern on the apical surface of cells in protruding
structures indicative of microvilli (figure 10A, B). To confirm that
these structures bear all the structural hallmarks typical of
microvilli, they were examined at high magnification by TEM.
As with full-length Podocalyxin, DDTHL and Dtail mutants each
clearly demonstrated the presence of actin filaments in the
microvillar core (figure 10C, D). In summary, Podocalyxin is able
to recruit actin to microvilli in the absence of the bulk of its
cytoplasmic domain, but the extracellular domain is essential for
this process.
DISCUSSION
Podocalyxin’s role in determining cellular
morphology
Experiments from the 1970’s suggested that highly-glycosylated
and sialylated glycoproteins play a key role in maintaining the
integrity of the foot processes of kidney podocytes [24,25,29]. With
the subsequent identification of Podocalyxin as the major
component of the podocyte glycocalyx and the tight correlation
between its expression and podocyte morphogenesis in vivo, this
molecule became the prime candidate as a regulator of foot
process formation [5,30,31,32]. Our gene targeting studies
confirmed this: although Podocalyxin deficient animals generate
podocyte precursors, these cells fail to undergo morphogenesis [2].
Figure 9. Podocalyxin colocalizes with ezrin in a manner indepen-
dent of any direct interaction with NHERF-1. (A) Vertical slices of
confocal stacks demonstrate increased apical recruitment of ezrin in
Podocalyxin-transfected MCF-7 cells. Green: ectopic Podocalyxin, red:
endogenous ezrin, blue: nuclei (DAPI). Scale bar: 5 mm. (B) Projections of
merged apical confocal images of MCF-7 cells transfected with various
Podocalyxin constructs or empty vector. Green: Podocalyxin, red: ezrin
(or isotype control for ezrin), blue: DAPI. White numbers represent
Pearson’s colocalization coefficient. Scale bar: 5 mm. (C) In vitro pull-
down assays with biotinylated Podocalyxin cytoplasmic tail (PCT)
peptides and GST-N’ezrin reveal a lack of interaction between
a Podocalyxin peptide representing the cytoplasmic tail of the Dtail
mutant (HQRF) and ezrin. Biotinylated Podocalyxin peptides bound to
streptavidin-sepharose were incubated with GST-N’ezrin or GST alone,
and bound recombinant proteins were detected with an anti-GST-
antibody by Western blot.
doi:10.1371/journal.pone.0000237.g009
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expression of Podocalyxin (Nielsen et al, in preparation). In the
current experiments, we extend these observations and find that
rather than being a podocyte-specific phenomenon, expression of
Podocalyxin is sufficient for induction of morphogenesis and
microvillus formation in epithelial cell lines. Importantly, endog-
enous Podocalyxin is normally expressed and apically targeted in
mammary epithelium [8] and the ovarian surface epithelium (J.
Cipollone and C. Roskelley, unpublished observations) in vivo
suggesting that this represents a normal biological process.
Podocalyxin’s activity as a cell morphogen is dependent on its
extracellular domain since mutants lacking this domain, though
apically targeted, are unable to form microvilli. Several previous
studies in vivo, though indirect, support this notion. For example,
treatment of kidney podocytes to neutralize the negatively charged
sialic acid residues on the podocyte surface leads to a dramatic loss
of podocyte interdigitating foot processes [24,25,29,33]. It is
therefore not surprising that deletion of the majority of Podocalyx-
in’s extracellular domain also prevents microvillus formation. A
caveat with this model, however, is our inability to detect a loss of
microvilli in neuraminidase-treated cells suggesting that, at least for
microvillus formation, the terminal sialic acid residues are dispens-
able. This discrepancy could reflect differences in 1) the cellular
contextofPodocalyxinexpression(podocytesversusotherepithelia),
2) the size of the structures formed (foot processes versus microvilli),
or 3) the microenvironment of the treated cells (in vivo kidney
podocytes versus cultured breast epithelial cells). Supporting these
observations, it has been noted that neuraminidase treatment of
kidney podocytes in vivo leads to a disruption of the interaction
between Podocalyxin and ezrin while treatment of Podocalyxin
expressing MDCK cells does not [15,21]. Importantly, it has
recently been demonstrated that mice bearing a glycosyltransferase
mutation that prevents terminal glycosylation of Podocalyxin have
a much milder phenotype than the complete Podocalyxin knockout
that we previously generated [2,34]. Thus, further work will be
required to determine the degree to which specific glycosylations
regulate Podocalyxin’s ability to orchestrate microvillus assembly.
Although the precise mechanism by which Podocalyxin induces
microvillus formation is unclear, it may be largely biophysical; the
formation of microvilli may simply serve as a mechanism to
distribute Podocalyxin’s bulky extracellular domains more evenly
across the cell surface. In this model, an increasing amount of cell
surface Podocalyxin would lead to an increasing expansion of the
apical domain of these cells (figure 11A). Continued expression
would lead to marginalization of cell-cell junctions and, eventually,
a decrease in cell-cell contact and adhesion. This model is
consistent with the previous reports of a dose-dependent
weakening of cell junctions induced by ectopic expression of
Podocalyxin and the tight correlation between Podocalyxin
overexpression and breast cancer metastatic index [8,11]. It is
Figure 10. Podocalyxin colocalizes with f-actin at the apical surface of cells, even in the absence of most of Podocalyxin’s cytoplasmic tail. (A, B)
Podocalyxin-transfected MCF-7 cells with f-actin (red), ectopic Podocalyxin (green), and DAPI (blue) labeling. Scale bars: 5 mm. (A) Projections of
merged apical confocal images; white numbers represent Pearson’s colocalization coefficient. (B) Vertical slices of confocal stacks. (C, D) High
magnification TEM images demonstrate the presence of actin filaments (red arrows) running the length of individual microvilli. Although microvillio f
different lengths are shown in this figure, there was no consistent difference in microvilli lengths between samples. Scale bars: 0.1 mm. (C) Cross-
sections; (D) longitudinal-sections.
doi:10.1371/journal.pone.0000237.g010
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a ‘‘preapical’’ domain-forming protein [12].
While the overexpression of certain actin-associated intracellu-
lar proteins, such as espin and villin, have long been known to
stimulate microvillus formation [35,36], it has also been shown
recently that some transmembrane proteins can induce similar
phenotypes. In ovarian follicle cells, overexpression of Cad99C
(the Drosophila orthologue of the human Usher cadherin
PCDH15) increases microvillus length, and Cad99C-null flies
have shortened microvilli [37]. Similarly, overexpression of
syndecan-3 or the mucin, podoplanin, leads to filopodia formation
[38,39,40]. Thus, Podocalyxin is not the only transmembrane
protein that can induce formation of cell surface extensions. It is
also intriguing that, like Podocalyxin, podoplanin has been
proposed to play a functional role in metastatic carcinoma
progression by altering polarization rather than by initiating
a classical epithelial to mesenchymal transformation [8,39].
A more unique aspect of the present studies is the apparent
dispensability of Podocalyxin’s cytoplasmic domain, since micro-
villus formation is known to be associated with apical recruitment
of f-actin and ERM proteins. Deletion of the cytoplasmic domain
of syndecan-3, for example, dramatically reduces the number of
filopodia on transfected cells [40]. Similarly, although much of the
cytoplasmic portion of Cad99C can be deleted without affecting
microvillus length, the residual 31 intracellular amino acids may
contain recognition sites for cytoplasmic adapter molecules or
cytoskeletal components [37]. Thus, we provide the first example
demonstrating the absolute necessity of an extracellular domain, in
the absence of a cytoplasmic domain, in formation of microvilli. In
addition, our results demonstrate that Podocalyxin-dependent
formation of microvilli does not require direct interaction with
NHERF proteins (detailed further below) [12,14,15,16,19].
How does Podocalyxin induce membrane
projections?
Although we have shown that the extracellular and transmem-
brane domains are sufficient for generation of microvilli, there are
several possible mechanisms that could lead to this effect
(figure 11A). As stated above, Podocalyxin could have a passive
or biophysical role involving apical membrane expansion. In this
scenario epithelial cells would cope with this Podocalyxin-
dependent apical domain expansion (possibly as a consequence
of a unique property of its extensive glycosylation) by passively
creating membrane projections that are subsequently locked into
place by the linkage of other apically targeted proteins to the actin
cytoskeleton. Alternatively, we favor a model in which Podoca-
lyxin could play a more active role in microvillus production.
Podocalyxin’s extracellular domain could directly bind another
interacting transmembrane molecule that is able to recruit ezrin
and f-actin and induce direct production of microvilli rather than
passive apical domain expansion. This interaction may therefore
transduce the signal to initiate microvillus formation. Regardless of
the model, the retention of the microvillus formation phenotype in
the presence of neuraminidase suggests that this specific
glycosylation is not a prerequisite for this phenotype. Instead
Podocalyxin’s stalk or globular domain, or perhaps the remainder
of its bulky mucin-like domain, may be particularly important in
this interaction (under investigation).
What is the significance of NHERF recruitment to
apical domains by Podocalyxin?
Several groups have suggested that NHERF proteins are re-
sponsible for strict apical localization and membrane retention of
Podocalyxin [12,14,19]. In these studies, deletion of Podocalyxin’s
NHERF docking site led to a modest reduction in apical
Podocalyxin. Although we agree that loss of the NHERF binding
site may lead to a subtle relocalization of a small portion of
Podocalyxin, our studies demonstrating complete relocalization of
NHERF-1 from the cytoplasm to the apical membrane when full
length Podocalyxin is ectopically expressed argue that it is
primarily Podocalyxin that regulates the distribution of NHERF-
1 (and presumably other NHERF-bound signaling molecules)
rather than NHERF-1 regulating the distribution of Podocalyxin.
Although our results preclude a direct functional role for
Figure 11. Model of Podocalyxin’s functions. (A) Cells expressing low or no Podocalyxin have well-defined cell-cell junctions and adhere well to the
substratum. Overexpression of Podocalyxin leads to recruitment of f-actin to the apical membrane for formation of microvilli along with apical
domain expansion and weakening of cell-cell junctions. Higher expression induces further recruitment of f-actin to the apical surface, which may lead
to a decrease in basolateral actin and disruption of integrin-mediated cell-substratum adhesion. Two models are proposed to explain Podocalyxin’s
mechanism of action. (B) In the absence of Podocalyxin expression NHERF-1 is localized throughout the cytoplasm, whereas in cells expressing high
levels of Podocalyxin NHERF-1 is recruited to the apical membrane. Thus, Podocalyxin may regulate NHERF’s role in many biological processes.
doi:10.1371/journal.pone.0000237.g011
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apical cell domains, apical recruitment of NHERF-1 by Podoca-
lyxin is likely to be very important for other aspects of NHERF
function, which include ion transport, signal transduction, growth
control, receptor signaling, and receptor internalization. Re-
garding the latter, NHERF can bind a wide variety of signaling
ligands (ie. EGFR, PDGFR, b-catenin, PTEN, and adrenergic and
purinergic receptors, to name but a few) with functional
consequences [18,41]. The fact that Podocalyxin is a potent
inducer of NHERF recruitment to microvilli may suggest a new
link between the formation of these specialized structures and
these diverse biological processes. Regardless, the dramatic
Podocalyxin-dependent recruitment of NHERF-1 to the apical
plasma membrane likely affects NHERF-1’s activity as a signaling
scaffold (figure 11B).
Podocalyxin and microvilli in cell adhesion and
cancer
In most situations Podocalyxin appears to act as an anti-adhesion
molecule [2,11]. For example, we have shown that Podocalyxin
expression is upregulated in metastatic breast cancer cells and that
it induces delamination of these cells from monolayers [8]. Given
our present results, it is not unreasonable to suggest that this
function may be closely linked to Podocalyxin’s ability to generate
microvilli. Specifically, Podocalyxin-coated, microvilli-rich apical
domains on free surfaces may protect cells from non-specific
adhesion to extracellular matrices, regardless of the polarization
state of the cells. Thus, Podocalyxin overexpression in breast
carcinomas may promote tumor cell dissemination by initiating
a general disruption of cell adhesion, particularly under conditions
where apical membrane domains are expanded due to breakdown
in polarity. Such a novel mechanism of invasive tumor cell
dissemination, which has also been proposed for podoplanin [39],
may be clinically important in the most prevalent ductal breast
carcinoma subtype as these tumors rarely undergo dissemination
by a recognizable epithelial to mesenchymal transformation
[42,43].
It is also interesting to speculate that the recruitment of f-actin to
the apical membrane for microvillus formation might deplete actin
from the basal surface of these cells [19] and thereby prevent
stable interactions between integrins and the extracellular matrix.
In ovarian carcinoma cells this may be the case as Podocalyxin
overexpression decreases integrin recruitment to the cell-extracel-
lular matrix interface (J. Cipollone and C. Roskelley, unpublished
observations). This hypothesis is further supported by the
observation that cells transfected with full-length Podocalyxin or
mutants lacking its cytoplasmic tail generate abundant microvilli
and exhibit decreased cell-substratum adhesion, while cells
transfected with Podocalyxin lacking the extracellular domain do
not generate microvilli and remain adherent ([8], figure 11A, and
unpublished observations). Future studies delineating the mechan-
isms by which apical Podocalyxin and basolateral integrins
compete for actin will clarify this process.
MATERIALS AND METHODS
Antibodies
Primary antibodies were mouse monoclonals against ezrin
(biotinylated 3C12: NeoMarkers, Fremont CA and purified
3C12: Abcam, Cambridge UK), chicken Podocalyxin (Mep21)
[44], the VSV epitope for detecting VSV-tagged N’ezrin (P5D4:
Sigma-Aldrich, Oakville ON), and the flag epitope for detecting
the flag-tagged DEC mutant (biotinylated M2: Sigma-Aldrich),
a rat monoclonal against mouse Podocalyxin (MBL, Woburn MA),
and polyclonal rabbit antibodies against NHERF-1 (EBP50:
Abcam) and GST (Santa Cruz Biotechnology, Santa Cruz, CA).
Secondary antibodies were Alexa Fluor 488 conjugated goat anti-
mouse or rabbit IgG, Alexa Fluor 568 conjugated goat anti-mouse
IgG1, rat IgG, or streptavidin, Alexa Fluor 647 conjugated goat
anti-rat or rabbit IgG (Invitrogen, Burlington ON), biotinylated
goat anti-rat IgG (Southern Biotech, Birmingham AL), APC
conjugated goat anti-mouse Ig or streptavidin (BD Biosciences,
Mississauga ON), and horseradish peroxidase conjugated goat
anti-rabbit Ig (DAKO, Mississauga, ON). Rabbit IgG (Jackson
ImmunoResearch Laboratories, Westgrove PA) and biotin-conju-
gated mIgG1 (R&D Systems, Minneapolis MN) were used as
isotype controls. F-actin was detected with Alexa Fluor 568 or
rhodamine conjugated phalloidin (Invitrogen); DAPI was used for
nuclear staining (Sigma).
DNA Constructs and Podocalyxin mutants
Murine Podocalyxin cDNA was a generous gift from Dr. David
Kershaw; chicken Podocalyxin cDNA was cloned from HD100
hematopoietic progenitor cells [3]. Podocalyxin mutants were
generated by PCR from cDNA using primers designed to insert
early stop codons after the juxtamembrane HQRF sequence
(Dtail) or before the C-terminal DTHL (DDTHL). The DEC
mutant was generated by replacing Podocalyxin’s mucin and
globular extracellular sequences with CD43’s signal peptide and
a flag-tag motif, generously provided by Wooseok Seo and
Dr. Hermann Ziltener. PCR products were cloned into TOPO
(Invitrogen), then pIRES2-EGFP (BD Biosciences), and se-
quenced in the final constructs. VSV-tagged dominant
negative (N-terminal) ezrin was a generous gift from Dr.
Monique Arpin.
Cell culture, transfection, and cell sorting
MCF-7 human breast carcinoma and MDCK canine kidney
epithelial cells were routinely maintained in Advanced D-MEM/
F12 medium (Invitrogen #12634-010) supplemented with 5%
fetal bovine serum, penicillin, streptomycin, and glutamine. Some
experiments were performed in both high and low serum to assess
whether these conditions altered protein localization or microvillus
formation, but we concluded that there was no difference. Cells
were transfected with 30 mg pIRES2-EGFP (BD Biosciences), or
the same vector containing Podocalyxin cDNA, using the
DMRIE-C transfection reagent (Invitrogen). Stable transfectants
were selected by culturing in 400 mg/ml G418 and sorted for GFP
or Podocalyxin-positive bulk populations or clones using a BD
FACS Vantage. For actin disruption experiments, transfected cells
were treated with 10 mm latrunculin A (Sigma-Aldrich) in media
for 10 minutes before fixation. For dominant negative ezrin
experiments, cells stably expressing ectopic murine Podocalyxin
were transiently transfected with VSV-tagged N’ezrin, replated
12 hours post-transfection or not replated, and fixed 36 hours
post-transfection.
Electron microscopy
Cells were grown on filters (TEM) or glass coverslips (SEM), fixed,
and processed for electron microscopy. Images were collected
using a Philips 300 electron microscope (TEM) or a Hitachi S4700
FESEM. Figures were arranged using Adobe Photoshop and
Adobe Illustrator software. Microvilli were enumerated in six
random 15 0006(50 mm
2) fields for each sample. Statistical
significance was demonstrated using T-tests to compare vector
versus Podocalyxin-transfected cells (or wildtype Podocalyxin
versus DEC-transfected cells in the case of the DEC mutant).
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Cells were grown on glass coverslips, fixed with 4% para-
formaldehyde, permeabilized with 0.1% Triton X-100, labeled
with primary and secondary antibodies (described above), and
examined using an Olympus Fluoview FV1000 confocal micro-
scope. Triple-labeled images were collected sequentially. Micro-
graphs were generated with several merged confocal planes or
vertical sections of confocal stacks using Olympus Fluoview
FV1000 software (version1.3b). Pearson’s coefficient was used to
quantitate colocalization on individual slices using ImagePro 3DS
6.0 software. Photos were arranged with Adobe Photoshop and
Adobe Illustrator software.
In vitro binding assay using purified recombinant
proteins
Biotinylated Podocalyxin tail peptides were produced with a spacer
and the following sequences: HQRF (the cytoplasmic tail of the
Dtail mutant), HQRFSQKKSQQRLTEELQ (partial tail of
Podocalyxin including the ezrin binding site), and the full-length
Podocalyxin cytoplasmic tail. A pGEX construct encoding the N-
terminal domain of ezrin fused with GST was a generous gift from
Dr. Monique Arpin. GST and GST-N’ezrin were produced
according to manufacturer’s instructions (Amersham Biosciences,
Piscataway, NJ). Biotinylated Podocalyxin peptides (4.3 nmol)
were bound to streptavidin-sepharose (Amersham Biosciences),
and then incubated for 2 hours at 4uC with 20 mg GST or an
equimolar amount of GST-N’ezrin in 150 mM NaCl, 20 mM Tris
(pH7), and 0.2% Triton X-100 containing 1 mM PMSF and
a protease inhibitor cocktail (Sigma-Aldrich). Bound proteins were
detected by immmunoblotting using an anti-GST antibody.
SUPPORTING INFORMATION
Video S1A Podocalyxin induces apical domain expansion and
NHERF-1 recruitment. 3D rotated reconstructions of MCF-7 cells
transfected with (A) empty vector or (B) murine Podocalyxin
showing Podocalyxin (red), NHERF-1 (green), and DAPI (blue)
labeling. The 3D images were generated from confocal stacks and
re-sliced down the Z axis every 5 mM along the Y axis using
Olympus FluoView1000 imaging software. The resulting movies
were modified using ImagePro Plus Discovery 3D (Media
Cybernetics).
Found at: doi:10.1371/journal.pone.0000237.s001 (26.65 MB
AVI)
Video S1B Podocalyxin induces apical domain expansion and
NHERF-1 recruitment. 3D rotated reconstructions of MCF-7 cells
transfected with (A) empty vector or (B) murine Podocalyxin
showing Podocalyxin (red), NHERF-1 (green), and DAPI (blue)
labeling. The 3D images were generated from confocal stacks and
re-sliced down the Z axis every 5 mM along the Y axis using
Olympus FluoView1000 imaging software. The resulting movies
were modified using ImagePro Plus Discovery 3D (Media
Cybernetics).
Found at: doi:10.1371/journal.pone.0000237.s002 (25.73 MB
AVI)
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